Track topics on Twitter Track topics that are important to you
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing innovative products to prevent and treat serious infectious diseases. The Companyâs pipeline includes FV-100, which is in Phase II clinical development for the treatment of shingles; INX-189, a nucleotide polymerase inhibitor in Phase I clinical development for the treatment of chronic hepatitis C infections; and a staphylococcal vaccine based on its proprietary MSCRAMM protein platform that is partnered with Pfizer and currently in Phase I clinical development.
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing innovative products to prevent and treat serious infectious diseases. T...
We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infecti...
We have published hundreds of Inhibitex, Inc. news stories on BioPortfolio along with dozens of Inhibitex, Inc. Clinical Trials and PubMed Articles about Inhibitex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inhibitex, Inc. Companies in our database. You can also find out about relevant Inhibitex, Inc. Drugs and Medications on this site too.
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...